Pharmafile Logo

MedTech specialist joins Research Partnership

June 21, 2022 | Medtech 

Janet Powers has joined the company as a Director in the MedTech division.

We are delighted to announce that Janet Powers has joined the company as a Director in the MedTech division. Based in the US, Janet has worked in healthcare her entire career and has over 21 years of experience in research and consulting. She brings strong MedTech experience to the team having worked with most of the top 25 firms in the industry.

Janet most recently served as Senior Vice President of Research at MedPanel overseeing all qualitative and quantitative projects, recruitment and panel development. Other previous roles include Director of Business Intelligence at Philips Healthcare and Vice President of Analysis at Eliza Corporation.

Head of the MedTech Division, Sabera Hyderally said of her appointment, “I am delighted to welcome Janet to the MedTech Division. She brings a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with a researcher of her calibre as we continue our tremendous growth globally.”

Speaking about the appointment, Co-CEO Mary Assimakopoulos said, “We are very pleased that Janet has chosen to join Research Partnership. She has previously worked with a range of MedTech clients and brings a great depth of experience to the team, which aims to stay at the forefront of best practice and innovation.”

Visit researchpartnership.com to find out more.

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Blog: The Cost of Counterfeits

The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.

Video: Self-pay and Emerging Markets

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

News: Research Partnership launches new patient report – Living with Ulcerative Colitis

Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...

Summer Intern experience at Research Partnership

We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

Beyond Andrology: Trends in Men’s Health in Emerging Markets

Published in eyeforpharma July 2016 by Rachel Howard

Infographic: HIV Market Snapshot

Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...

Infographic: The vaccine opportunity in Asia

As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...

Webinar: What next for biosimilars?

Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST

Understanding the Patient Journey

The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme.  Technology...